Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2024 07:30 ET | Source: Optimi Health Corp.

Optimi Announces Non-Brokered Private Placement

Optimi Announces Non-Brokered Private Placement
February 06, 2024 07:30 ET | Source: Optimi Health Corp.

Optimi Health To Host MDMA Educational Quality Assurance Webinar For Clinicians And Practitioners

Highlights: Optimi Chief Science and Quality Assurance experts to provide in-depth access into the Company’s safety and quality standards.Optimi experts will address critical inquiries which still...
January 03, 2024 07:30 ET | Source: Optimi Health Corp.

Optimi Health Granted Precursor Licence To Formulate MDMA And Completes Encapsulation Of 40mg And 60mg Dosage Formats

Optimi Health Granted Precursor Licence for 3,4-Methylenedioxyphenyl-2-propanone (“MDP2P”), the precursor used in the chemical synthesis of MDMA.